NCT00146068View on ClinicalTrials.gov

EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Multiple Sclerosis

Interventions

DRUG

Avonex/Zocor

Trial Locations (1)

27599

University of North Carolina-Chapel Hill MS clinic within the Neuroscience Hospital, Chapel Hill

All Listed Sponsors

lead

University of North Carolina

OTHER

NCT00146068 - EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis | Biotech Hunter | Biotech Hunter